Indefinite Delivery Contract SPE2DB24D9144
Award Date
2/28/24
Last Date to Order
12/31/25
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award indefinite delivery contract worth up to $499,999,999 from the Defense Logistics Agency (DLA). The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Key categories of goods to be delivered include prescription drugs,...
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 by the Defense Logistics Agency (DLA). The contract, number 4600082063, is for the procurement of a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. Products include tablets, capsules, injections, creams, solutions, and other drug forms spanning...
The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract, SPE2DB, to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $499,999,999, has a period of performance through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. The products include flumazenil...
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
The Defense Logistics Agency (DLA) has awarded DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 through November 2026. This IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military healthcare facilities nationwide. The contract covers an...
The Defense Logistics Agency has awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a variety of pharmaceutical and medical supplies. The single-award contract has a potential value of up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will deliver pharmaceutical items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which runs through November 2026, covers a diverse portfolio of branded and...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. Through this contract, DMS Pharmaceutical...
DMS Pharmaceutical Group Inc., a woman-owned small business, holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities...
The Department of Defense (DoD) has awarded DMS Pharmaceutical Group Inc., a woman-owned small business, a single-award Indefinite Delivery Contract (IDC) under the SPE2DB program with the Defense Logistics Agency (DLA). The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of...